CHRNA7 and Parkinson disease: Based on these findings, the activation of α7nAChRs might exert beneficial effects on PD not only by decreasing neuroinflammation but also by regulating the differentiation of the CD4+ T cell subsets, which might be a promising therapeutic approach for PD.